Publikationen in Zusammenarbeit mit Forschern von Universidad Austral (20)

2022

  1. 30-day morbidity and mortality of sleeve gastrectomy, Roux-en-Y gastric bypass and one anastomosis gastric bypass: a propensity score-matched analysis of the GENEVA data

    International Journal of Obesity, Vol. 46, Núm. 4, pp. 750-757

  2. Osteotomies of the second phalanx of the great toe: A clinical experience

    Foot, Vol. 53

2021

  1. SPARC inhibition accelerates NAFLD-associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism

    Liver International, Vol. 41, Núm. 7, pp. 1677-1693

2020

  1. Ethical issues about the paradigm shift in the treatment of children with trisomy 18

    European Journal of Pediatrics, Vol. 179, Núm. 3, pp. 493-497

2019

  1. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets

    Journal of Hepatology, Vol. 71, Núm. 1, pp. 78-90

  2. Multicenter Study of the Psychometric Properties of the New Demoralization Scale (DS-II) in Spanish-Speaking Advanced Cancer Patients

    Journal of Pain and Symptom Management, Vol. 57, Núm. 3, pp. 627-634

2018

  1. Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia

    Respiratory Medicine, Vol. 140, pp. 115-121

2016

  1. Encuentro sobre educación de cuidado paliativo en Latinoamérica. Recomendaciones sobre enseñanza en el pregrado y en el primer nivel de atención de salud

    Medicina Paliativa, Vol. 23, Núm. 1, pp. 42-48

2015

  1. Nivolumab and urelumab enhance antitumor activity of human T lymphocytes engrafted in Rag2-/-IL2Rγnull immunodeficient mice

    Cancer Research, Vol. 75, Núm. 17, pp. 3466-3478

2014

  1. Leadership of a palliative care team - A personal view

    European Journal of Palliative Care

  2. Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins

    Clinical Cancer Research, Vol. 20, Núm. 22, pp. 5697-5707

2013

  1. Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein

    Cancer Research, Vol. 73, Núm. 1, pp. 139-149

  2. Interleukin-15 in gene therapy of cancer

    Current Gene Therapy, Vol. 13, Núm. 1, pp. 15-30

2012

  1. The liver, liver metastasis and liver cancer: A special case for immunotherapy with cytokines and immunostimulatory monoclonal antibodies

    Immunotherapy, Vol. 4, Núm. 11, pp. 1081-1085

2011

  1. Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma

    Cancer Immunology, Immunotherapy, Vol. 60, Núm. 10, pp. 1383-1395

2010

  1. A phase i clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma

    Cancer Gene Therapy, Vol. 17, Núm. 12, pp. 837-843

2009

  1. Teaching dying patient care in three universities in Argentina, Spain, and Italy

    Journal of Palliative Medicine, Vol. 12, Núm. 7, pp. 603-607

2007

  1. A worldwide perspective of atypical pathogens in community-acquired pneumonia

    American Journal of Respiratory and Critical Care Medicine, Vol. 175, Núm. 10, pp. 1086-1093

  2. Cumplimiento con las guias nacionales en pacientes hospitalizados con neumonia adquirida en la comunidad. Resultados del estudio CAPO en Argentina

    Medicina, Vol. 67, Núm. 6 II, pp. 709-713

  3. Immunotherapy and immunoescape in colorectal cancer

    World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5822-5831